Acute leukemias after treatment with radioiodine for thyroid cancer.
Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.
Roldán Schilling
V
V
Fernández Abellán
P
P
Domínguez Escribano
J R
JR
Rivas González
C
C
Mut Barberá
E
E
Calatayud Cendra
R
R
D000328:Adult; D002291:Carcinoma, Papillary / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D015473:Leukemia, Promyelocytic, Acute / Q000209:etiology*; D007953:Leukemia, Radiation-Induced / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000209:etiology*; D013964:Thyroid Neoplasms / Q000532:radiotherapy*
D007457:Iodine Radioisotopes